{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:18:32Z","timestamp":1761175112422,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015274","name":"Ministerio de Salud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijid.2021.09.047","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T08:11:20Z","timestamp":1632471080000},"page":"288-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antiretroviral therapy use in selected countries in Latin America during 2013\u20132017: results from the Latin American Workshop in HIV Study Group"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-4591","authenticated-orcid":false,"given":"Pedro","family":"Zitko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-5420","authenticated-orcid":false,"given":"Martin","family":"Hojman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Sabato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-7131","authenticated-orcid":false,"given":"Rosana","family":"Cuini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4847-4742","authenticated-orcid":false,"given":"Liliana","family":"Calanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Contarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Teran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Bakolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Chaverri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-5277","authenticated-orcid":false,"given":"Miguel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-8908","authenticated-orcid":false,"given":"Ana-Belen","family":"Arauz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Moncada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Thormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijid.2021.09.047_bib0001","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1016\/S2352-3018(16)30090-X","article-title":"Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial","volume":"3","author":"Amanyire","year":"2016","journal-title":"Lancet HIV"},{"year":"2015","series-title":"Protocolo de Atencion Integral en ITS\/VIH\/SIDA","key":"10.1016\/j.ijid.2021.09.047_bib0002"},{"year":"2017","series-title":"Estandares para el diagnostcio y tratamiento del VIH\/SIDA en Latinoamerica","key":"10.1016\/j.ijid.2021.09.047_bib0003"},{"issue":"6","key":"10.1016\/j.ijid.2021.09.047_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158560","article-title":"Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis","volume":"11","author":"Avila-Rios","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijid.2021.09.047_bib0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0956462415584487","article-title":"Evaluation of patient care cascade for HIV-positive patients diagnosed in La Romana, Dominican Republic in 2011: a retrospective cohort study","volume":"27","author":"Bowman","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"8","key":"10.1016\/j.ijid.2021.09.047_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001290","article-title":"Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings","volume":"9","author":"Campbell","year":"2012","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.ijid.2021.09.047_bib0007","first-page":"448","article-title":"The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital","volume":"40","author":"Cesar","year":"2016","journal-title":"Rev Panam Salud Publica"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2021.09.047_bib0008","article-title":"HIV in Ecuador: A Current Perspective of the Epidemics from a Major HIV Care Center","volume":"4","author":"Cevallos","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2021.09.047_bib0009","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-154-7-201104050-00316","article-title":"Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1","volume":"154","author":"Daar","year":"2011","journal-title":"Ann Intern Med"},{"issue":"10159","key":"10.1016\/j.ijid.2021.09.047_bib0010","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"DALYs, G.B.D","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijid.2021.09.047_bib0011","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1086\/424009","article-title":"Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults","volume":"39","author":"DeJesus","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.047_bib0012","unstructured":"European AIDS Clinical Society (EACS). (2018). GUIDELINES Version 9.1, October 2018."},{"issue":"10","key":"10.1016\/j.ijid.2021.09.047_bib0013","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e32833a2a14","article-title":"Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts","volume":"24","author":"Ford","year":"2010","journal-title":"Aids"},{"key":"10.1016\/j.ijid.2021.09.047_bib0014","article-title":"The MANGUA Project: A Population-Based HIV Cohort in Guatemala","volume":"2015","author":"Garcia","year":"2015","journal-title":"AIDS Res Treat"},{"issue":"10","key":"10.1016\/j.ijid.2021.09.047_bib0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40266-013-0107-7","article-title":"Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals","volume":"30","author":"Ghidei","year":"2013","journal-title":"Drugs Aging"},{"year":"2019","series-title":"Guia de Manejo Antiretroviral de las Personas con VIH","key":"10.1016\/j.ijid.2021.09.047_bib0016"},{"year":"2010","series-title":"Guia de Refercnia Rapida. Tratamiento Antiretroviral del Paciente Adulto con Infeccion por VIH. GPC","key":"10.1016\/j.ijid.2021.09.047_bib0017"},{"year":"2018","series-title":"Guia de Manejo Antiretroviral de las Personas con VIH","key":"10.1016\/j.ijid.2021.09.047_bib0018"},{"issue":"9","key":"10.1016\/j.ijid.2021.09.047_bib0019","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ijid.2021.09.047_bib0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"7414","key":"10.1016\/j.ijid.2021.09.047_bib0021","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"year":"2017","series-title":"Guia de Practica Clinica Basada en Evidencia: VIH\/SIDA en Adultos (Actualizacion)","key":"10.1016\/j.ijid.2021.09.047_bib0022"},{"issue":"10","key":"10.1016\/j.ijid.2021.09.047_bib0023","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/09540121.2015.1046416","article-title":"Barriers to access to care reported by women living with HIV across 27 countries","volume":"27","author":"Johnson","year":"2015","journal-title":"AIDS Care"},{"year":"2014","series-title":"90-90-90. An ambitious treatment target to help end the AIDS epidemic","key":"10.1016\/j.ijid.2021.09.047_bib0024"},{"key":"10.1016\/j.ijid.2021.09.047_bib0025","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). (2018). UNAIDS DATA 2018. Retrieved from"},{"key":"10.1016\/j.ijid.2021.09.047_bib0026","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). (2019). UNAIDS DATA 2019. Retrieved from"},{"issue":"7","key":"10.1016\/j.ijid.2021.09.047_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002357","article-title":"Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial","volume":"14","author":"Koenig","year":"2017","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.ijid.2021.09.047_bib0028","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1365-3156.2011.02828.x","article-title":"Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review","volume":"16","author":"Kranzer","year":"2011","journal-title":"Trop Med Int Health"},{"issue":"11","key":"10.1016\/j.ijid.2021.09.047_bib0029","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.2018.1818","article-title":"Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial","volume":"319","author":"Labhardt","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.047_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0b013e3181da1287","article-title":"Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses","volume":"55","author":"Lennox","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.047_bib0031","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0b013e3181b05f7c","article-title":"Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naive subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine\/zidovudine and efavirenz in study GS-01-934","volume":"52","author":"Margot","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"year":"2017","series-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica S\u00edndrome de Inmunodeficiencia Adquirida VIH\/SIDA 2017","key":"10.1016\/j.ijid.2021.09.047_bib0032"},{"year":"2014","series-title":"Norma Tecnica de Salud de Atencion Integral del Adjulto con Infeccion por Virus de la Inmunodeficiencia Humana (HIV)","key":"10.1016\/j.ijid.2021.09.047_bib0033"},{"key":"10.1016\/j.ijid.2021.09.047_bib0034","unstructured":"Ministerio de Salud del Peru. (2018). Norma Tecnica de Salud de Atencion Integral del Adjulto con Infeccion por Virus de la Inmunodeficiencia Humana (HIV)."},{"key":"10.1016\/j.ijid.2021.09.047_bib0035","unstructured":"Ministerio de Salud Publica de Ecuador. (2018). Prevencion, Diagnostioc y Tratamiento de la Infeccion por el Virus de Inmunodeficiencia Jumana (VIH) en embarazadas, nino, adolescentes y adultos."},{"year":"2018","series-title":"Guia Nacional de Atencion a la Poblacion Adulta con VIH\/SIDA","key":"10.1016\/j.ijid.2021.09.047_bib0036"},{"year":"2018","series-title":"Guia Practica para la Atencion integral de Personas Adultas con VIH en el Primer Nivel de Atencion","key":"10.1016\/j.ijid.2021.09.047_bib0037"},{"year":"2014","series-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica (GPC) basada en la evidencia cient\u00edfica para la atenci\u00f3n de la infecci\u00f3n por VIH\/Sida en adolescentes (con 13 a\u00f1os de edad o m\u00e1s) y adultos","key":"10.1016\/j.ijid.2021.09.047_bib0038"},{"year":"2013","series-title":"Antiretroviral Treatment in the Spotlight: A Public Health Analysis in Latin America and the Caribbean 2013. Washington, DC","key":"10.1016\/j.ijid.2021.09.047_bib0039"},{"key":"10.1016\/j.ijid.2021.09.047_bib0040","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. US Department of Health and Human Services (DHHS). (2019). Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Retrieved from http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf."},{"issue":"7","key":"10.1016\/j.ijid.2021.09.047_bib0041","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(15)00108-5","article-title":"The HIV care continuum in Latin America: challenges and opportunities","volume":"15","author":"Pi\u00f1eir\u00faa","year":"2015","journal-title":"Lancet Infect Dis"},{"year":"2017","series-title":"Decreato N38374-S que oficializa Norma para la Atncion Integral de Personas con VIH\/SIDA","key":"10.1016\/j.ijid.2021.09.047_bib0042"},{"year":"2014","series-title":"Guia de Tratamiento Antiretroviral de las PErsonas que Viven con el VIH\/SIDA en Venezuela","key":"10.1016\/j.ijid.2021.09.047_bib0043"},{"issue":"4","key":"10.1016\/j.ijid.2021.09.047_bib0044","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11904-011-0098-0","article-title":"Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011","volume":"8","author":"Puskas","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.047_bib0045","doi-asserted-by":"crossref","first-page":"20636","DOI":"10.7448\/IAS.19.1.20636","article-title":"Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression","volume":"19","author":"Rebeiro","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.047_bib0046","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAI.0b013e31828ace69","article-title":"Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir\/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK","volume":"63","author":"Rockstroh","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.ijid.2021.09.047_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002015","article-title":"Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial","volume":"13","author":"Rosen","year":"2016","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.ijid.2021.09.047_bib0048","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/QAD.0000000000001549","article-title":"Zidovudine use in pregnancy and congenital malformations","volume":"31","author":"Rough","year":"2017","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.ijid.2021.09.047_bib0049","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2018.8431","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel","volume":"320","author":"Saag","year":"2018","journal-title":"JAMA"},{"issue":"(2","key":"10.1016\/j.ijid.2021.09.047_bib0050","article-title":"Plasma efavirenz concentrations are associated with lipid and glucose concentrations","volume":"95","author":"Sinxadi","year":"2016","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.ijid.2021.09.047_bib0051","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/S2352-3018(20)30358-1","article-title":"Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study","volume":"8","author":"Smiley","year":"2021","journal-title":"The Lancet HIV"},{"issue":"11","key":"10.1016\/j.ijid.2021.09.047_bib0052","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1473-3099(11)70301-2","article-title":"HIV drug and supply stock-outs in Latin America","volume":"11","author":"Sued","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.ijid.2021.09.047_bib0053","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","article-title":"Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection","volume":"369","author":"Walmsley","year":"2013","journal-title":"N Engl J Med"},{"year":"2016","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for treating and Preventing HIV infection Recommendatios for A Public Health Approach","key":"10.1016\/j.ijid.2021.09.047_bib0054"},{"key":"10.1016\/j.ijid.2021.09.047_bib0055","unstructured":"World Health Organization. (2017). HIV drug resistance report 2017. Retrieved from"},{"year":"2019","series-title":"Update of recommendations on first- and second-line antiretroviral regimens","key":"10.1016\/j.ijid.2021.09.047_bib0056"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.047_bib0057","first-page":"16","article-title":"[Characteristics of HIV care in 44 centers form 11 countries in Latin America; results of the Latin American Workshop Study Group]","volume":"18","author":"Zitko","year":"2016","journal-title":"Rev Panam Infectol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:07:56Z","timestamp":1761120476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221007554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":57,"alternative-id":["S1201971221007554"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.047","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiretroviral therapy use in selected countries in Latin America during 2013\u20132017: results from the Latin American Workshop in HIV Study Group","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}